Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury - PubMed (original) (raw)
Review
Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury
Pramod K Dash et al. Neurotherapeutics. 2010 Jan.
Abstract
Traumatic brain injury (TBI) remains a serious health concern, and TBI is one of the leading causes of death and disability, especially among young adults. Although preventive education, increased usage of safety devices, and TBI management have dramatically increased the potential for surviving a brain injury, there is still a need to develop reliable methods to diagnose TBI, the secondary pathologies associated with TBI, and predicting the outcomes of TBI. Biomarkers (changes of amount or activity in a biomolecule that reflect injury or disease) have shown promise in the diagnosis of several conditions, including cancer, heart failure, infection, and genetic disorders. A variety of proteins, small molecules, and lipid products have been proposed as potential biomarkers of brain damage from TBI. Although some of these changes have been reported to correlate with mortality and outcome, further research is required to identify prognostic biomarkers. This need is punctuated in mild injuries that cannot be readily detected using current techniques, as well as in defining patient risk for developing TBI-associated secondary injuries.
Copyright 2010 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
- Biomarkers in the clinical diagnosis and management of traumatic brain injury.
Hergenroeder GW, Redell JB, Moore AN, Dash PK. Hergenroeder GW, et al. Mol Diagn Ther. 2008;12(6):345-58. doi: 10.1007/BF03256301. Mol Diagn Ther. 2008. PMID: 19035622 - [Diagnostic biomarkers in traumatic brain injury].
Wanke-Jellinek L, van Griensven M, Biberthaler P. Wanke-Jellinek L, et al. Unfallchirurg. 2014 Aug;117(8):693-8. doi: 10.1007/s00113-013-2542-7. Unfallchirurg. 2014. PMID: 25116011 Review. German. - Advances in diagnosis, treatments, and molecular mechanistic studies of traumatic brain injury.
Lu C, Xia J, Bin W, Wu Y, Liu X, Zhang Y. Lu C, et al. Biosci Trends. 2015 Jun;9(3):138-48. doi: 10.5582/bst.2015.01066. Biosci Trends. 2015. PMID: 26166367 Review. - Clinical applications of biomarkers in pediatric traumatic brain injury.
Sandler SJ, Figaji AA, Adelson PD. Sandler SJ, et al. Childs Nerv Syst. 2010 Feb;26(2):205-13. doi: 10.1007/s00381-009-1009-1. Epub 2009 Nov 10. Childs Nerv Syst. 2010. PMID: 19902222 Review. - The role of biomarkers and MEG-based imaging markers in the diagnosis of post-traumatic stress disorder and blast-induced mild traumatic brain injury.
Huang M, Risling M, Baker DG. Huang M, et al. Psychoneuroendocrinology. 2016 Jan;63:398-409. doi: 10.1016/j.psyneuen.2015.02.008. Epub 2015 Feb 23. Psychoneuroendocrinology. 2016. PMID: 25769625
Cited by
- Systemic and cerebro-cardiac biomarkers following traumatic brain injury: an interim analysis of randomized controlled clinical trial of early administration of beta blockers.
El-Menyar A, Asim M, Khan N, Rizoli S, Mahmood I, Al-Ani M, Kanbar A, Alaieb A, Hakim S, Younis B, Taha I, Jogol H, Siddiqui T, Hammo AA, Abdurraheim N, Alabdallat M, Bahey AA, Ahmed K, Atique S, Chaudry IH, Prabhu KS, Uddin S, Al-Thani H. El-Menyar A, et al. Sci Rep. 2024 Aug 23;14(1):19574. doi: 10.1038/s41598-024-70470-y. Sci Rep. 2024. PMID: 39179700 Free PMC article. Clinical Trial. - Shock index and its variants as predictors of mortality in severe traumatic brain injury.
Carteri RB, Padilha M, de Quadros SS, Cardoso EK, Grellert M. Carteri RB, et al. World J Crit Care Med. 2024 Mar 9;13(1):90617. doi: 10.5492/wjccm.v13.i1.90617. eCollection 2024 Mar 9. World J Crit Care Med. 2024. PMID: 38633479 Free PMC article. - Neurotrauma-From Injury to Repair: Clinical Perspectives, Cellular Mechanisms and Promoting Regeneration of the Injured Brain and Spinal Cord.
Stevens AR, Belli A, Ahmed Z. Stevens AR, et al. Biomedicines. 2024 Mar 13;12(3):643. doi: 10.3390/biomedicines12030643. Biomedicines. 2024. PMID: 38540256 Free PMC article. Review. - Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties.
Pandya JD, Musyaju S, Modi HR, Okada-Rising SL, Bailey ZS, Scultetus AH, Shear DA. Pandya JD, et al. J Transl Med. 2024 Feb 16;22(1):167. doi: 10.1186/s12967-024-04908-2. J Transl Med. 2024. PMID: 38365798 Free PMC article. Review. - Advanced Tuneable Micronanoplatforms for Sensitive and Selective Multiplexed Spectroscopic Sensing via Electro-Hydrodynamic Surface Molecular Lithography.
Gomes PC, Hin-Chu M, Rickard JJS, Goldberg Oppenheimer P. Gomes PC, et al. Adv Sci (Weinh). 2024 Mar;11(12):e2306068. doi: 10.1002/advs.202306068. Epub 2024 Jan 15. Adv Sci (Weinh). 2024. PMID: 38225756 Free PMC article.
References
- Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004;351:13–22. - PubMed
- Okie S. Traumatic brain injury in the war zone. N Engl J Med. 2005;352:2043–2047. - PubMed
- Holcomb JB, Stansbury LG, Champion HR, Wade C, Bellamy RF. Understanding combat casualty care statistics. J Trauma. 2006;60:397–401. - PubMed
- Kochanek PM, Clark RS, Ruppel RA, et al. Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: Lessons learned from the bedside. Pediatr Crit Care Med. 2000;1:4–19. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources